• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Concord Drugs Ltd — Board Meeting, 14-02-2026: Board Meeting

    14-02-2026 | 04:37 pm

    Concord Drugs Ltd. Board approved Q3 & 9M Dec 2025 financials. Consolidated revenue hit ₹4.53 Cr, profit ₹0.04 Cr. Also, ₹13.36 Cr raised via preferential issue with no fund deviation. Committees reconstituted, director tenure ended.

    No comments yet. Be the first to comment!

    All announcements from Concord Drugs Ltd